Zhejiang Tailin Bioengineering300813.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Zhejiang Tailin Bioengineering (300813.SZ) trades at a P/E of 107.00x, P/B of 3.15x, P/S of 7.52x, and a dividend yield of 0.63%.
Longitudinal percentile comparison: P/E sits at the 60th percentile over the trailing 10Y window (vs. 16th percentile over 3Y); P/B sits at the 17th percentile over the trailing 10Y window (vs. 37th percentile over 3Y); P/S sits at the 17th percentile over the trailing 10Y window (vs. 37th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 78th percentile within its industry and the 82nd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.58%, ranking at the 96th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 43.2 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Breaking down the total shareholder yield: 0.63% comes from cash dividends, with an implied ~0.95% from buybacks — a fairly balanced mix of both channels. Zhejiang Tailin Bioengineering operates in the Machine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 300813 · SZSE: 300813 · 300813
Want the full picture on whether Zhejiang Tailin Bioengineering (300813.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 107.00 | ||||||
| P/B (MRQ) | 3.15 | ||||||
| P/S (TTM) | 7.52 | ||||||
| Dividend Yield | 0.63% | ||||||
| Buyback + Div Yield | 1.58% |